Picture of OptimizeRx logo

OPRX — OptimizeRx News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyAdventurousSmall CapSuper Stock

Optimizerx Corp Expected To Post A Loss Of 1 Cent A Share: Earnings Preview

* OPTIMIZERx Corp  OPRX.OQ   OPRX.O  is expected to show a
rise in
quarterly revenue when it reports  results on May 4. 
    * The Rochester Michigan-based  company is expected to
report  a
24.4% increase in revenue to $13.97 million from $11.23 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for OPTIMIZERx Corp is
for a
loss of 1 cent per share. For the same quarter last year, the
company reported earnings of 3 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 10.8%
in the last three months. ​
    * Wall Street's median 12-month price target for OPTIMIZERx
Corp
is $88​, above​ its last closing price of $28.62. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  0.22        0.21       0.22      Beat    7.3
 Sep. 30 2021  0.13        0.13       0.09      Missed  -31.8
 Jun. 30 2021  0.07        0.07       0.10      Beat    38.9​
 Mar. 31 2021  -0.01       0.01       0.03      Beat    275
 ​​Dec.        0.16        0.16       0.16      Met     3.2
 31 2020                                                
 Sep. 30 2020  0.04        0.04       0.07      Beat    75​
 Jun. 30 2020  -0.03       -0.03      0.02      Beat    166.7
 Mar. 31 2020  -0.03       -0.03      -0.06     Missed  -100
 This summary was machine generated May 3 at 02:03 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on OptimizeRx

See all news